Spruce provides independent medical imaging evaluation services using its SPRUCE OS platform, which integrates project management and efficacy analysis for clinical research. The company focuses on delivering standardized, objective assessments of imaging data for both oncology and non-oncology drug trials, enhancing the efficiency of clinical development processes.
Funding
Funding not disclosed
Founders
Product
Problem
Pharmaceutical companies and clinical research organizations (CROs) face challenges in ensuring the consistency and objectivity of medical image analysis during clinical trials, which can impact the accuracy and reliability of efficacy assessments for new drugs. Traditional methods often lack standardized workflows and integrated data management, leading to inefficiencies and potential biases in image evaluation.
Solution
Spruce provides independent medical imaging evaluation services, streamlining project management and efficacy analysis through its SPRUCE OS platform. The company delivers standardized, objective assessments of imaging data for oncology and non-oncology drug trials, enhancing the efficiency and accuracy of clinical development processes. Spruce's solution incorporates a CTMS (clinical trial management system) to visualize project management, connect data collection and cleaning with evaluation, and standardize the delivery of assessment data. The platform also ensures data anonymity and randomization based on study design, promoting independence and scientific rigor.
Target Audience
The primary target audience includes pharmaceutical companies and clinical research organizations involved in oncology and non-oncology drug trials.
Features
- CTMS integration for streamlined project management and data handling
- Role-based access controls and data anonymization to ensure data security and integrity
- Integrated PACS (Picture Archiving and Communication System) functionality for medical image storage and communication
- Customizable modules for various assessment standards, ensuring efficient and accurate results
- Advanced image post-processing capabilities, including PET-CT fusion and SUV value calculation
- Capabilities for clinical endpoint assessments, pathology, ECG, and endoscopy evaluations
- Support for subject eligibility assessment, disease progression confirmation, and MDT analysis
- Consulting services for protocol and efficacy evaluation design, expert communication, and regulatory guidance